BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27025205)

  • 1. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients.
    Fortún J; Martín-Dávila P; Gomez Garcia de la Pedrosa E; Silva JT; Garcia-Rodríguez J; Benito D; Venanzi E; Castaño F; Fernández-Ruiz M; Lazaro F; García-Luján R; Quiles I; Cabanillas JJ; Moreno S; Aguado JM
    J Infect; 2016 Jun; 72(6):738-744. PubMed ID: 27025205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the galactomannan test for the diagnosis of invasive pulmonary aspergillosis using non-invasive proximal airway samples.
    Chun JY; Jeong SJ; Kim S; Choi S; Lee JH; Chung HS; Park S; Lee H; Kim HY; Hwangbo B; Choi YJ
    J Infect; 2024 Jun; 88(6):106159. PubMed ID: 38641139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease.
    Buil JB; Huygens S; Dunbar A; Schauwvlieghe A; Reynders M; Langerak D; van Dijk K; Bruns A; Haas PJ; Postma DF; Biemond B; Delma FZ; de Kort E; Melchers WJG; Verweij PE; Rijnders B
    J Clin Microbiol; 2023 May; 61(5):e0004423. PubMed ID: 37097150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid.
    Egger M; Penziner S; Dichtl K; Gornicec M; Kriegl L; Krause R; Khong E; Mehta S; Vargas M; Gianella S; Porrachia M; Jenks JD; Venkataraman I; Hoenigl M
    J Clin Microbiol; 2022 Apr; 60(4):e0021522. PubMed ID: 35350844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.
    D'Haese J; Theunissen K; Vermeulen E; Schoemans H; De Vlieger G; Lammertijn L; Meersseman P; Meersseman W; Lagrou K; Maertens J
    J Clin Microbiol; 2012 Apr; 50(4):1258-63. PubMed ID: 22301025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay.
    Zhang S; Wang S; Wan Z; Li R; Yu J
    Biomed Res Int; 2015; 2015():943691. PubMed ID: 25685819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients.
    Zhu N; Zhou D; Xiong W; Zhang X; Li S
    Front Cell Infect Microbiol; 2023; 13():1271853. PubMed ID: 38029249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different lateral flow assays on bronchoalveolar lavage fluid for invasive aspergillosis screening in non-hematological patients.
    Devillers E; Scherer E; Navellou JC; Grenouillet F; Millon L; Bellanger AP
    J Mycol Med; 2024 Jun; 34(2):101481. PubMed ID: 38718721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
    Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
    Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the JF5-based Aspergillus galactomannoprotein lateral flow device for diagnosing invasive aspergillosis in cancer patients.
    Wan L; Cai X; Ling M; Kan J; Yin M; Wang H
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1221-1229. PubMed ID: 38625450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia.
    Dellière S; Amar Y; Hamane S; Aissaoui N; Denis B; Bergeron A; Tazi A; Alanio A
    Med Mycol; 2023 Dec; 61(12):. PubMed ID: 37996394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metagenomic next-generation sequencing for detecting
    Shi Y; Peng JM; Hu XY; Yang QW; Wang Y
    Front Cell Infect Microbiol; 2023; 13():1209724. PubMed ID: 38188627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience.
    Acet-Öztürk NA; Ömer-Topçu D; Vurat Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Özkalemkaş F; Ener B; Ali R; Akalın H
    Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):33-43. PubMed ID: 37910269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis-A pilot study.
    Ajayababu A; Singh G; Meena VP; Upadhyay AD; Rana B; Sethi P; Prakash B; Singh A; Vyas S; Sinha S; Xess I; Wig N; Kabra SK; Ray A
    Mycoses; 2024 Jan; 67(1):e13695. PubMed ID: 38282361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis.
    Fisher CE; Stevens AM; Leisenring W; Pergam SA; Boeckh M; Hohl TM
    Transpl Infect Dis; 2014 Jun; 16(3):505-10. PubMed ID: 24725139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Utility of Galactomannan and Polymerase Chain Reaction Assays in Bronchoalveolar Lavage for Diagnosis of Chronic Pulmonary Aspergillosis.
    Chowdhury M; Singh G; Pandey M; Mishra H; Meena VP; Sethi P; Singh A; Prakash B; Upadhyay AD; Mohan A; Sinha S; Xess I; Wig N; Kabra SK; Ray A
    Mycopathologia; 2023 Dec; 188(6):1041-1053. PubMed ID: 37857979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of galactomannan test with bronchoalveolar lavage and serum for the diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Gupta A; Capoor MR; Shende T; Sharma B; Mohindra R; Suri JC; Gupta DK
    J Lab Physicians; 2017; 9(4):234-238. PubMed ID: 28966482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic efficacy of metagenomic next generation sequencing in bronchoalveolar lavage fluid for proven invasive pulmonary aspergillosis.
    Jia H; Liu H; Tu M; Wang Y; Wang X; Li J; Zhang G
    Front Cell Infect Microbiol; 2023; 13():1223576. PubMed ID: 37692168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum signatures for invasive pulmonary aspergillosis in patients with underlying respiratory diseases (SPARED): study protocol for a prospective diagnostic trial.
    Xiao W; Gong DY; Mao B; Du XM; Cai LL; Wang MY; Fu JJ
    BMC Infect Dis; 2018 Jun; 18(1):271. PubMed ID: 29890956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.